American Heart Journal
Volume 154, Issue 1 , Pages 62-70 , July 2007

Baseline platelet reactivity in acute myocardial infarction treated with primary angioplasty—Influence on myocardial reperfusion, left ventricular performance, and clinical events

Received 1 October 2006 ,Accepted 15 March 2007.

References 

  1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227–1234
  2. Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res. 2004;61:498–511
  3. Favaloro EJ. Clinical application of the PFA-100. Curr Opin Hematol. 2002;9:407–415
  4. Harrison P. Progress in the assessment of platelet function. Br J Haematol. 2000;111:733–744
  5. Frossard M, Fuchs I, Leitner JM, et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation. 2004;110:1392–1397
  6. Kupatt C, Habazettl H, Hanusch P, et al. c7E3Fab reduces postischemic leukocyte-thrombocyte interaction mediated by fibrinogen. Implications for myocardial reperfusion injury. Arterioscler Thromb Vasc Biol. 2000;20:2226–2232
  7. Lefer AM, Campbell B, Scalia R, et al. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation. 1998;98:1322–1328
  8. Choudhri TF, Hoh BL, Zerwes HG, et al. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest. 1998;102:1301–1310
  9. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase 1 findings. N Engl J Med. 1985;312:932–936
  10. Van't Hof AWJ, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction-myocardial blush grade. Circulation. 1998;97:2302–2306
  11. Schroder R, Dissmann R, Bruggemann T, et al. Extent of early ST-segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol. 1994;24:384–391
  12. Schroder R, Wegscheider K, Schroder K, et al. Extent of early ST-segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol. 1995;26:1657–1664
  13. Claeys MJ, Bosmans J, Veenstra L, et al. Determinants and prognostic implications of persistent S-T segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation. 1999;99:1972–1977
  14. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367
  15. Poli A, Fetiveau R, Vandoni P, et al. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty. Circulation. 2002;106:313–318
  16. Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93:1993–1999
  17. Henriques JP, Zijlstra F, van 't Hof AW, et al. Angiographic assessment of reperfusion in acute myocardial infarction by Myocardial Blush Grade. Circulation. 2003;107:2115–2119
  18. Hansen PR. Inflammatory alterations in the myocardial microcirculation. J Mol Cell Cardiol. 1998;30:2555–2559
  19. Gawaz M, Neumann FJ, Dickfeld T, et al. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation. 1997;96:1809–1818
  20. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med. 1998;187:329–333
  21. Heindl B, Zahler S, Welsch U, et al. Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts. Cardiovasc Res. 1998;38:383–394
  22. Santoso S, Sachs UJ, Kroll H, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med. 2002;196:679–691
  23. Diacovo TG, Roth SJ, Buccola JM, et al. Neutrophil rolling, arrest, and transmigration across activated, surface adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood. 1996;88:146–157
  24. Campo G, Vagimigli M, Gemmati D, et al. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention. J Am Coll Cardiol. 2006;48:2178–2185
  25. Gerber BL, Rochitte CE, Melin JA, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation. 2000;101:2734–2741
  26. Serebruany VL, Yurovsky VV, Gurbel PA. Mild myocardial stunning affects platelet aggregation and certain hemostatic factors in swine. Clin Appl Thromb Hemost. 1999;5:236–242
  27. Madan M, Berkowitz SD, Christie DJ, et al. Rapid assessment of glycoprotein IIb/IIIa blockade using the platelet function analyzer (PFA-100) during percutaneous coronary interventions. Am Heart J. 2001;141:226–233
  28. Madan M, Berkowitz SD, Douglas JC, et al. Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100. Am Heart J. 2002;144:151–158
  29. Gianetti J, Parri MS, Sbrana S, et al. Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty. A 6 months prospective study. Thromb Res. 2006;118:487–493
  30. Fuchs I, Frossard M, Spiel A, et al. Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J Thromb Heamost. 2006;4:2547–2552
  31. Sambola A, Heras M, Escolar G, et al. The PFA-100 detects sub-optimal platelet responses in patients on aspirin. Platelets. 2004;15:439–446
  32. Sudic D, Razmara M, Forslund M, et al. High glucose levels enhance platelet activation: involvement of multiple mechanisms. Br J Heamatol. 2006;133:315–322
  33. John S, Schneider MP, Delles C, et al. Lipid-independent effect of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J. 2005;149:473.e1–473.e10
  34. Angiolillo DJ, Bernardo E, Ramirez C, et al. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. J Am Coll Cardiol. 2006;48:298–304
  35. Takahashi S, Ushida M, Komine R, et al. Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with platelet responsiveness to in vitro effect of aspirin. Thromb Res. 2007;119:517–524
  36. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention. Am J Cardiol. 2006;97:38–43
  37. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty patterns of left ventricular dilatation and long-term prognostic implications. Circulation. 2002;106:2351–2357

 Supported by grants from the Polish State Committee for Scientific Research (KBN 2 P05C 045 26 and KBN 3 P05B 122 23).

PII: S0002-8703(07)00243-8

doi: 10.1016/j.ahj.2007.03.021

American Heart Journal
Volume 154, Issue 1 , Pages 62-70 , July 2007

Article Tools

* Image Usage & Resolution